Novel Oral Anticoagulants in Peripheral Arterial and Coronary Artery Disease
2014
Atherosclerosis comprises of a chronic disease of the vessels which mainly targets the arterial system. The
disease’s main characteristic is the accumulation of inflammatory cells, lipids, smooth muscle cells and connective tissue
within the vascular intima layer. The atherosclerotic lesion can be more accurately defined as a fibro-inflammatory lipid
plaque. The pathogenesis of the atherosclerotic plaque is a progressive and additive process that usually occurs over
decades. Antiplatelet and anticoagulant agents have been the major elements of large trials since decades, in an attempt to
promote the primary and secondary prevention of atherothrombosis. The atherosclerotic plaque rupture and the following
thrombosis involve, among others, activation of both platelets and coagulation factors, therefore a potential combination
of antiplatelet and anticoagulant therapy, particularly in the setting of secondary prevention has been reconsidered in the
light of the newly developed oral anticoagulants.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
5
Citations
NaN
KQI